Related Experiment Video
Updated: Jan 29, 2026

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
Published on: June 6, 2020
Genome-Scale CRISPR/Cas9 Screening Reveals Squalene Epoxidase as a Susceptibility Factor for Cytotoxicity of
Yukio Koizumi1, Jun Fukushima2, Yayoi Kobayashi2
1Department of Biochemistry and Metabolic Science, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan.
Abstract:
Malformin A1 (MA1) is a fungus-produced cyclic pentapeptide. MA1 exhibits teratogenicity to plants, fibrinolysis-enhancing activity, and cytotoxicity to mammalian cells. To clarify the cytotoxic mechanism of MA1, we screened for the genes involved in the cytotoxicity of MA1 in monocytoid U937 cells by using a CRISPR/Cas9-based genome-wide knockout library. Screening was performed by positive selection for cells that were resistant to MA1 treatment, and single guide RNAs (sgRNAs) integrated into MA1-resistant cells were analyzed by high-throughput sequencing. As a result of the evaluation of sgRNAs that were enriched in MA1-resistant cells, SQLE, which encodes squalene epoxidase, was identified as a candidate gene. SQLE-depleted U937 cells were viable in the presence of MA1, and squalene epoxidase inhibitor conferred MA1 resistance to wild-type cells. These results indicate that squalene epoxidase is implicated in the cytotoxicity of MA1. This finding represents a new insight into applications of MA1 for treating ischemic diseases.
Insights
Malformin A1 (MA1) is cytotoxic to mammalian cells. Researchers identified squalene epoxidase as a key factor in MA1
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Malformin A1 (MA1), a cyclic pentapeptide from fungi, demonstrates cytotoxicity to mammalian cells.
- Understanding the cytotoxic mechanism of MA1 is crucial for potential therapeutic applications.
Purpose of the Study:
- To elucidate the molecular mechanism underlying Malformin A1-induced cytotoxicity.
- To identify host genes mediating sensitivity or resistance to MA1.
Main Methods:
- Utilized a CRISPR/Cas9 genome-wide knockout library for screening in U937 cells.
- Employed positive selection for MA1-resistant cells.
- Analyzed enriched single guide RNAs (sgRNAs) via high-throughput sequencing.
Main Results:
- Squalene epoxidase (SQLE) was identified as a critical gene involved in MA1 cytotoxicity.
- Depletion of SQLE conferred resistance to MA1 in U937 cells.
- Inhibition of squalene epoxidase also rendered wild-type cells resistant to MA1.
Conclusions:
- Squalene epoxidase plays a significant role in the cytotoxic effects of Malformin A1.
- This discovery offers novel insights into potential therapeutic strategies for ischemic diseases using MA1.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Genomics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
pH Scale

